
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
NATCO Pharma has launched its generic semaglutide in India at a significant discount, intensifying competition in the diabetes and weight-loss drug market after patent expiry.
Iran's strategy of publicly naming and then striking key energy assets in the Gulf has revealed significant vulnerabilities in US air defense systems and regional security.
Wipro commits $1 billion to its ai360 initiative, forging key partnerships with Microsoft, Google, and IBM to accelerate enterprise AI adoption and innovation.
DCX Systems Limited has secured a significant ₹68.05 crore order from Hindustan Aeronautics Limited for custom antennas and power supplies for airborne defence platforms.
As the conflict enters its third week, Iran dismisses a temporary truce, outlining three specific demands for a permanent end to hostilities with Israel and the US.
Ashok Leyland's Ras Al-Khaimah plant faces a 15-20% production drop due to supply chain disruptions from the Iran conflict, despite resilient regional demand.
Israel expands its conflict with Iran by striking naval assets in the Caspian Sea, prompting Iranian retaliation against critical energy facilities in Qatar and Kuwait.
The International Energy Agency has proposed 10 immediate measures, including remote work and speed limits, to reduce oil demand amid a historic supply disruption.
Devyani International, India's largest Yum Brands franchisee, has entered the Thai market by acquiring 274 KFC restaurants for $128.9 million in a strategic partnership.
Motilal Oswal reiterates a 'BUY' rating for LG Electronics India with a target price of Rs 1,860, citing strong demand, market share gains, and margin expansion.
Godawari Power and Ispat receives NCLT approval for its merger with Godawari Energy, alongside strategic investments into battery storage and solar power projects.
State Bank of India has received a significant tax demand of ₹63,375 crore for AY 2023-24, which the lender has disputed and plans to challenge legally.
Novo Nordisk's patent on semaglutide expires in India on March 20, 2026, paving the way for generic competition and a significant drop in drug prices.
Emcure Pharmaceuticals has launched Poviztra, a second brand of Novo Nordisk's semaglutide, entering India's competitive weight-loss drug market with a strategic pricing advantage.
Foreign portfolio investors withdrew ₹52,704 crore from Indian equities in early March 2026, driven by geopolitical tensions in West Asia and rising crude oil prices.
An overview of petrol and diesel prices across major Indian cities as of March 2026, detailing the factors behind daily revisions and recent price stability.